NEOTHETICS
Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market.
NEOTHETICS
Social Links:
Industry:
Health Care Pharmaceutical Therapeutics
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.Neothetics.com
Total Employee:
1+
Status:
Active
Contact:
1 858-750-1008
Total Funding:
35.3 M USD
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Current Employees Featured
Investors List
Domain Associates
Domain Associates investment in Series C - Neothetics
Alta Partners
Alta Partners investment in Series C - Neothetics
AKS Capital
AKS Capital investment in Series C - Neothetics
RusnanoMedInvest
RusnanoMedInvest investment in Series C - Neothetics
Andrea Holdings International
Andrea Holdings International investment in Series C - Neothetics
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series C - Neothetics
Numoda Capital Innovations
Numoda Capital Innovations investment in Series C - Neothetics
AMOREPACIFIC Ventures
AMOREPACIFIC Ventures investment in Series C - Neothetics
Domain Associates
Domain Associates investment in Series C - Neothetics
Alta Partners
Alta Partners investment in Series C - Neothetics
Official Site Inspections
http://www.Neothetics.com
- Host name: ec2-3-19-116-195.us-east-2.compute.amazonaws.com
- IP address: 3.19.116.195
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Neothetics"
Neothetics - Crunchbase Company Profile & Funding
Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market. Neothetics merged with Evofem Biosciences on Jan 17, 2018. Where is …See details»
Evofem Announces Closing of Merger With Neothetics
Jan 17, 2018 · The merged company will operate as Evofem Biosciences, Inc. and will focus on the continued development and commercialization of women’s healthcare products. The …See details»
Organization | Neothetics, Inc
Neothetics, Inc Report issue For profit Phase 2 Phase 3 Founded: San Diego CA United States (2007)See details»
Neothetics, Inc. and Evofem Biosciences, Inc. Announce
SAN DIEGO, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) and Evofem Biosciences, Inc. today announced they have entered into a definitive agreement …See details»
Neothetics Inc (NEOT) Wows Investors With New Merger …
Oct 17, 2017 · Neothetics director Martha Demski believes the merger will "provides the best opportunity to maximize value for Neothetics’ shareholders.” The merger will position the …See details»
Neothetics - Products, Competitors, Financials, Employees, …
Neothetics operates as a clinical-stage specialty pharmaceutical company. It develops injections for localized fat reduction and body contouring, offering a non-surgical procedure that helps …See details»
Evofem Announces Closing Of Merger With Neothetics
Jan 17, 2018 · The merged company will operate as Evofem Biosciences, Inc. and will focus on the continued development and commercialization of women's healthcare products. The …See details»
Neothetics and Evofem to merge (OTCMKTS:EVFM) - Seeking Alpha
Oct 17, 2017 · Neothetics (NEOT) and privately held Evofem Biosciences will merge in an all-stock deal that will result in Evofem shareholders owning 87% of the combined...See details»
Evofem Biosciences, Inc. completed the acquisition of Neothetics, …
Jan 16, 2018 · Evofem Biosciences, Inc. entered into an agreement to acquire Neothetics, Inc. (NasdaqCM:NEOT) in a reverse merger transaction on October 17, 2017. As specified in the …See details»
Neothetics - Funding, Financials, Valuation & Investors - Crunchbase
Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market.See details»
Neothetics Corporate Overview - static.seekingalpha.com
Neothetics Corporate Overview 16th Annual Needham Healthcare Conference 2017. 2 Safe Harbor Statement This presentation, including the accompanying oral presentation, may …See details»
Neothetics - LinkedIn
Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market.See details»
Company Neothetics Inc Nasdaq - MarketScreener.com
Jan 18, 2016 · Neothetics Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»
Neothetics, Inc. - VentureRadar
Neothetics is a clinical-stage specialty pharmaceutical company focused on development and commercialization of therapeutics for the aesthetic... ... Find out more about Neothetics, Inc., …See details»
Neothetics Inc and Evofem Biosciences Inc announce merger …
Oct 17, 2017 · * Neothetics Inc and Evofem Biosciences, Inc. announce merger agreement to create Women’S health company. * Neothetics Inc - privately-held Evofem Biosciences will …See details»
Neothetics - Contacts, Employees, Board Members, Advisors
Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market.See details»
Neothetics (NEOT) to Merge with Evofem Biosciences
Oct 17, 2017 · Neothetics, Inc. (NASDAQ: NEOT) and Evofem Biosciences, Inc. today announced they have entered into a definitive agreement under which privately-held Evofem Biosciences …See details»
Neothetics and Evofem Biosciences merge | Experience - Jones Day
Jones Day advised Invesco Asset Management Limited in connection with the merger of Evofem Biosciences, Inc. with a wholly owned subsidiary of Neothetics, Inc. and the purchase by …See details»
Susan Knudson - Chief Financial Officer @ Neothetics - Crunchbase
Susan A. Knudson has served as Chief Financial Officer of Neothetics™ since July 2014 and Vice President of Finance and Administration since February 2009. Knudson brings over 18 years …See details»
Biotech Neothetics pulls off a $65M IPO and promptly takes a …
Nov 21, 2014 · But the biotech still grossed $65 million, and, withi its proceeds, Neothetics plans to bankroll pivotal trials of its top prospect, an injectable therapy designed to reduce belly fat in …See details»